BMY

Bristol-Myers Squibb Company

Healthcare
67.66 +0.74 +1.11% Pre-Market
2026-09-02 • USD

Key Metrics

Market Cap 138.21B
EV 175.31B
Shares Out 2.04B
Revenue (ttm) 49.19B
Net Income 9.28B
Beta —
P/E —
Forward P/E —
EPS (ttm) $4.55
P/S 2.81
P/B 6.19
P/FCF 12.08
P/C 10.81
EV/Sales 3.56
EV/EBITDA 49.15
ROA 10.06%
ROE 45.42%
ROIC —
Gross Margin —
Oper. Margin —
Profit Margin 18.87%
Debt/Eq 2.05
LT Debt/Cap 65.35%
Quick Ratio 0.95
Current Ratio 1.53
Book/sh 10.93
Cash/sh 4.27
Div Yield 3.71%
Div TTM $2.51
Payout Ratio 55.16%
SMA20 2.67%
SMA50 8.41%
SMA200 16.8%
Volume 7,818,379
Avg Volume 11.56M
Rel Volume 0.68
Perf Week -0.04%
Perf Month 2.21%
Perf Quarter 22.30%
Perf Half Y 9.31%
Perf YTD 24.06%
Perf Year 40.88%
Perf 3Y 7.90%
Perf 5Y 2.00%

Factor Lens

Seasonal Performance

Dividends

Per-share amounts adjusted for stock splits.

Last Dividend $0.6300
TTM Yield 3.71%
TTM Amount $2.51
Payout Ratio 55.16%
3-Yr Growth (CAGR) 4.37%
5-Yr Growth (CAGR) 6.24%

Last 12 Payouts

Period Ex-Date Amount / Share
Q2 2026 ~2026-06-30 $0.6300
Q1 2026 ~2026-03-31 $0.6300
Q4 2025 ~2025-12-30 $0.6300
Q3 2025 ~2025-09-30 $0.6200
Q2 2025 ~2025-06-30 $0.6200
Q1 2025 ~2025-03-31 $0.6200
Q4 2024 ~2024-12-30 $0.6200
Q3 2024 ~2024-09-30 $0.6000
Q2 2024 ~2024-06-30 $0.6000
Q1 2024 ~2024-03-31 $0.6000
Q4 2023 ~2023-12-30 $0.6000
Q3 2023 ~2023-09-30 $0.5700

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Bristol-Myers Squibb Company is a global biopharmaceutical company dedicated to transforming patients' lives through science. The company discovers, develops and delivers…

Name
Bristol-Myers Squibb Company
Industry
Drug Manufacturers - General
CEO
Christopher S. Boerner · Board Chair and Chief Executive Officer
Employees
—
IPO Date
2019-03-12
Phone
(609) 252-4621
Address
Route 206 & Province Line Road, Princeton, NJ 08543
Website
—

Key Executives

Name Title FY Pay
Julia A. Haller Director —
Deepak L. Bhatt Director —
Peter J. Arduini Director —
Theodore R. Samuels Lead Independent Director —
Christopher S. Boerner Board Chair and Chief Executive Officer —

Latest News

Related stocks

Other companies in the same sector on MarketWalks.